Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Breast Neoplasms 3 Brain Neoplasms 2 Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Non-alcoholic Fatty Liver Disease 1 Multiple Myeloma 1 Intermittent Fasting 1 Fatty Liver 1 Estrogen Receptor-positive Breast Cancer 1 Endometrial Neoplasms 1 Drug Resistant Epilepsy 1 Autism Spectrum Disorder 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 9 pembrolizumab 7 Pemetrexed 7 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiation 4 Nivolumab 4 Bevacizumab 4 Platinum 3 Paclitaxel 3 Mastectomy, Segmental 3 Cisplatin 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 capmatinib 2 aldesleukin 2 Taxes 2 Radiotherapy, Conformal 2 Radiosurgery 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Anterior Temporal Lobectomy 2 1,2-diaminocyclohexaneplatinum II citrate 2 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Diet, Ketogenic × 1 year × Clear all

NCT07479095 2026-03-20

KETO-FDG Lung

Fondazione del Piemonte per l'Oncologia

Phase NA Recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡